First Capital Advisors Group’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $213K | Hold |
3,476
| – | – | 0.11% | 132 |
|
|
2023
Q1 | $218K | Hold |
3,476
| – | – | 0.14% | 127 |
|
|
2022
Q4 | $221K | Hold |
3,476
| – | – | 0.15% | 134 |
|
|
2022
Q3 | $205K | Hold |
3,476
| – | – | 0.17% | 134 |
|
|
2022
Q2 | $201K | Buy |
+3,476
| New | +$201K | 0.14% | 159 |
|
|
2018
Q4 | – | Sell |
-3,476
| Closed | -$207K | – | 171 |
|
|
2018
Q3 | $207K | Buy |
+3,476
| New | +$207K | 0.13% | 161 |
|
|
2018
Q2 | – | Sell |
-3,476
| Closed | -$171K | – | 586 |
|
|
2018
Q1 | $171K | Buy |
+3,476
| New | +$171K | 0.1% | 182 |
|